Meine Merkliste
my.bionity.com  
Login  

364 Aktuelle Marktstudien von Business Monitor International

rss

Sie können Ihre Recherche weiter verfeinern. Wählen Sie aus dem linken Bereich passende Suchfilter aus, um Ihre Ergebnisse gezielt einzugrenzen.

Cameroon Pharmaceuticals and Healthcare Report Q2 2012

BMI View: We believe Cameroon’s medium-to-long-term drug market expansion potential remains highly dependent on the country’s economic growth and is strongly linked to rising income and greater consumer purchasing power. The eeconomy is set for stable expansion over the next 10 years. As personal ...

mehr

Vietnam Pharmaceuticals and Healthcare Report Q2 2012

BMI View: The attractiveness of the Vietnamese pharmaceutical market to foreign investors will continue to be hampered by the country’s poor enforcement of intellectual property (IP) and the authorities limiting market access through distribution restrictions and mandatory domestic clinical ...

mehr

Uzbekistan Pharmaceuticals and Healthcare Report Q2 2012

BMI View: Uzbekistan’s pharmaceutical market remains one of the fastest growing in the Central and Eastern Europe (CEE) region and its population and currently low levels of per capita pharmaceutical spending gives it the greatest long-term growth potential of any Central Asian market. BMI ...

mehr

Iran Pharmaceuticals and Healthcare Report Q2 2012

BMI View: We continue viewing Iran as one of the less attractive regional markets. Imposition of more stringent international sanctions, rampant inflation, and the loss of confidence in the Iranian rial weigh heavily on consumption and investment patterns, and also on government revenues and the ...

mehr

Latvia Pharmaceuticals and Healthcare Report Q2 2012

BMI View: Despite a contraction in pharmaceutical prices, Latvia's pharmaceutical market performed strongly in first nine months of 2011, which has led to upward revisions to our outlook for 2011 and 2012. Latvia's attractiveness to multinationals will continue to be negatively affected by the ...

mehr

Namibia Pharmaceuticals and Healthcare Report Q2 2012

BMI View: Namibia’s pharmaceutical market represents a small but dependable proposition for multinational drugmakers operating in Sub-Saharan Africa. Steady economic growth and relative political stability underpin a healthcare system that is slowly reaching out to all parts of society. However, ...

mehr

Estonia Pharmaceuticals and Healthcare Report Q2 2012

BMI View: Estonia’s pharmaceutical market will remain of marginal interest to multinationals given its small population and a modest growth outlook. We expect the market to post a five-year compound annual growth rate (CAGR) of 5.07% in local currency terms through to 2016, with the following ...

mehr

Bahrain Pharmaceuticals and Healthcare Report Q2 2012

BMI View: Bahrain is a developed pharmaceutical market with patented drug spending accounting for over 83% of the total pharmaceutical expenditure in 2011. However, political unrest has dented investor confidence in the country, which also offers limited long-term pharmaceutical market potential ...

mehr

Indonesia Pharmaceuticals and Healthcare Report Q3 2012

BMI View: The government’s aim to create proper universal healthcare coverage is unlikely to be realised in the short term but would create investors’ interest in the country. We highlight some of the beneficiaries such as local generic drug manufacturers and medical devices suppliers. Given the ...

mehr

Brazil Pharmaceuticals and Healthcare Report Q2 2012

BMI View: Brazil remains the most attractive emerging pharmaceutical market in the Americas due to its large population, strong consumer demand, increasing urbanisation and comparatively good drug regulatory environment. Many multinational pharmaceutical companies reported double digital ...

mehr

Seite 2 von 37
Suche per e-Mail abonnieren

Sie erhalten passend zu Ihrer Suche die neusten Suchergebnisse per E-Mail. Dieser Service ist für Sie kostenlos und kann jederzeit abbestellt werden.

Ihr Bowser ist nicht aktuell. Microsoft Internet Explorer 6.0 unterstützt einige Funktionen auf Chemie.DE nicht.